DMAAU NASDAQ
Drugs Made In America Acquisition Corp. Units
1W: +0.0%
1M: +1.9%
3M: +3.6%
YTD: +4.6%
1Y: +5.8%
$10.89
-0.10 (-0.91%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$551
+0.0% ▲
Total Liabilities
$796
+0.0% ▲
Shareholders Equity
-$244
+0.0% ▲
Cash & Investments
$1K
+0.0% ▲
Total Debt
$662
+0.0% ▲
Net Debt
$661
+0.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2024 |
|---|---|
| — Assets — | |
| Cash | $1K |
| Short-Term Investments | $0 |
| Cash & ST Investments | $1K |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| Total Current Assets | $5K |
| Property, Plant & Equip. | $0 |
| Goodwill & Intangibles | $0 |
| Long-Term Investments | $0 |
| Other Non-Current Assets | $546 |
| Total Non-Current Assets | $546 |
| Total Assets | $551 |
| — Liabilities — | |
| Accounts Payable | $0 |
| Short-Term Debt | $662 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $56 |
| Total Current Liabilities | $796 |
| Long-Term Debt | $0 |
| Other Non-Current Liab. | $0 |
| Total Non-Current Liabilities | $0 |
| Total Liabilities | $796 |
| — Equity — | |
| Common Stock | $986 |
| Retained Earnings | -$279 |
| Accumulated OCI | $0 |
| Total Stockholders Equity | -$244 |
| Total Liabilities & Equity | $551 |
| — Key Metrics — | |
| Total Debt | $662 |
| Net Debt | $661 |
| Total Investments | $0 |